HEIDELBERG, Germany, Nov 17 (Bernama-PRNewswire) — European Wellness Academy (EWA), a member of European Wellness Biomedical Group (EWBG), recently signed its second research contract involving General In Vitro/In Vivo Safety and Toxicity Tests for Preclinical Studies of Regenerative Peptides with Heidelberg University.
The research contract signed is a continuation of the previous research on the efficacy of the Group’s cutting-edge biotherapeutics including precursor (progenitor) stem cells (PSC), precursor cells (Frozen Organo Crygenics (FOC)), Mito Organelles (MO), Nano Organo Peptides (NOP) and exosomes.
- European Countries Urge EU To Toughen Stance On Israel
- Israel’s Gaza City Takeover Steps Signal Dangerous Phase With Devastating Consequences: UN Chief
- Croatia To Provide One-Million-Euro Humanitarian Aid To Gaza: Minister
- Security Council Extends Mandate Of UN Force In Lebanon For Final Time
- Three More Palestinian Camps In Lebanon Hand Over Weapons To Army
- U.S. Disease Control Chief Fired Less Than One Month In Position
- Russia Says It Hit Ukrainian Military-Industrial Enterprises, Airbases
- U.S. Envoy Cuts Short Lebanon Border Tour Amid Protests, Backlash Over Press Remarks
- All UN Security Council Members, Except U.S., Call For Gaza Ceasefire
- Israeli Strikes Hit Southern Damascus Countryside